Clinical evaluation of a new drug for the treatment of ancylostomiasis.
D000724:Ancylostomiasis / Q000188:drug therapy*; D000871:Anthelmintics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D013861:Thiocyanates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced
D000871:Anthelmintics; D013861:Thiocyanates